Carver Kyle 4
4 · Evommune, Inc. · Filed Nov 7, 2025
Insider Transaction Report
Form 4
Evommune, Inc.EVMN
Carver Kyle
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-11-05+279,408→ 279,408 totalExercise: $16.00Exp: 2035-11-04→ Common Stock (279,408 underlying)
Footnotes (1)
- [F1]One fourth (1/4) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.